SCHEMBL24152365

SCHEMBL24152365

CCC(c1ccc(F)cc1F)N(C)S(=O)(=O)c1ccc2c(c1)/C(=C\c1nccs1)C(=O)N2C

nearest known ligand 0.34

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ TRPA1 O75762 1/20 0.34
▸ BRD4 O60885 2/20 0.32
▸ CA1 P00915 1/20 0.31
▸ CA2 P00918 1/20 0.31
▸ PTGS1 P23219 1/20 0.31
▸ PTGS2 P35354 1/20 0.31
▸ MAOA P21397 2/20 0.31
▸ MAOB P27338 1/20 0.31
▸ CASP3 P42574 1/20 0.31
▸ GPR139 Q6DWJ6 1/20 0.30
▸ SCN9A Q15858 2/20 0.30
▸ NR1I2 O75469 1/20 0.30
▸ SCN1A P35498 1/20 0.30
▸ SCN1B Q07699 1/20 0.30
▸ SCN5A Q14524 1/20 0.30
▸ SCN8A Q9UQD0 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24152366 0.83 RORC (0.32) SCN9A
SCHEMBL24153262 0.83 TRPA1 (0.36) TRPA1CA1CA2PTGS1PTGS2
SCHEMBL24152352 0.82 MAOA (0.41) TRPA1BRD4CA1CA2PTGS1
SCHEMBL24152458 0.81 TRPA1 (0.35) TRPA1BRD4CA1CA2PTGS1
SCHEMBL24153260 0.81 TRPA1 (0.36) TRPA1CA1CA2MAOAMAOB
SCHEMBL24151584 0.79 TRPA1 (0.42) TRPA1CASP3SCN1ASCN1BSCN5A
SCHEMBL24152819 0.79 RXFP1 (0.34) TRPA1BRD4CA1CA2PTGS1
SCHEMBL24152504 0.78 TAS2R14 (0.41) TRPA1PTGS1PTGS2MAOAMAOB
SCHEMBL24152367 0.78 TRPA1 (0.41) TRPA1CASP3SCN1ASCN1BSCN5A
SCHEMBL24153263 0.78 TRPA1 (0.38) TRPA1BRD4CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021260722-A1 DESIGN, SYNTHESIS OF NOVEL OXYINDOLE INHIBITORS OF DENV RNA DEPENDENT RNA POLYMERASE TRANSLATIONAL HEALTH SCIENCE AND TECHNOLOGY INSTITUTE (IN) 2021-12-30 — — WO disclosed
Send feedback